Overview
For further information: https://robertsinstitute.weill.cornell.edu
Blander Lab Website: https://www.theblanderlab.org
Highlights
- 1Nature immunology · 2022
- 2Nature immunology · 2025
- 3Nature immunology · 2021
Publications
Funding
Active
10 grants- KPMultidisciplinary Research Training in Gastroenterology and HepatologyNational Institute of Diabetes and Digestive and Kidney Diseases · 2019–2030Training· 2 renewals
- KPA novel T cell vaccine candidate: Leveraging antigen cross-presentation pathways to generate cross-reactive pan-Coronavirus specific CD8 T cellsCharles H. Revson Foundation Inc. · 2026–202926-34 (BWF 1058676)
- Sub-PIToward LNP Vaccine Immune-Interception for Childhood Cancer Predisposition SyndromesAlex's Lemonade Stand Foundation · 2025–2029 · via Hospital For Sick ChildrenHFSC 251126-01
- MPIImmunogenicity of lipid nanoparticlesNational Institute of Allergy and Infectious Diseases · 2024–2028 · via Cornell University - IthacaR01AI178125-02
- KPInnate sensing of inflammatory cell death in the intestinal epitheliumCrohn's and Colitis Foundation of America · 2025–2028CCFA 1455095
- PIToll-like receptor control of endocytic antigen cross-presentationNational Institute of Allergy and Infectious Diseases · 2023–2028R01AI170832-04
- PIMobilizing TAP-Independent CD8 T cells Through Non-Canonical Cross-PresentationNational Institute of Allergy and Infectious Diseases · 2023–2027R01AI170897-04
- PIDistinct Adaptive Repair Responses to Cell Death Modes in the Intestinal EpitheliumKenneth Rainin Foundation · 2025–2027KRF 20260059
- PIDistinct Adaptive Repair Responses to Cell Death Modes in the Intestinal EpitheliumKenneth Rainin Foundation · 2025–2026KRF 20250291
Completed grants (22)
- PIModulating XIAP for the Treatment of Inflammatory Bowel Diseases (IBD)United States Israel Binational Science Foundation · 2022–2025BSF 222059-03
- PIModulating XIAP for the Treatment of Inflammatory Bowel DiseaseNational Institute of Allergy and Infectious Diseases · 2023–2025R21AI178327-02
- PIToll-like Receptor Control of MHC Class I EndocytosisNational Institute of Allergy and Infectious Diseases · 2022–2024R21AI159772-02
- KPHypoxic incubator for physiological cell culture researchOffice of the Director, NIH · 2022–2023S10OD032317-01
- Sub-PIPan-Coronavirus Vaccine Development ProgramCornell University - Ithaca · 2022–2022 · via Weill Cornell Medical CollegeCUI 222775-01
- PIInnate and Adaptive Immune Consequences of NecroptosisNational Institute of Allergy and Infectious Diseases · 2020–2022R21AI154294-02
- PIRole of Apoptosis in the Intestinal Epithelium During Homeostasis and DiseaseNational Institute of Diabetes and Digestive and Kidney Diseases · 2017–2022R01DK111862-04
- PINon-Canonical Cross-Presentation in Dendritic Cells Upon TAP BlockadeNational Institute of Allergy and Infectious Diseases · 2016–2022R01AI123284-02
- PIMicrobial education of hematopoietic stem cellsWeill Cornell Medical College · 2021–2021Seed Grant 211744
- PIImporting OP9 CellsNational Institutes of Health · 2018–2021ContractNIH 191201-01
- PINovel Vita-Vaccine Formula Combines Safety of Dead and Efficacy of Live VaccinesNational Institute of Allergy and Infectious Diseases · 2017–2021R01AI127658-02
- PIInvestigators in the Pathogenesis of Infectious Disease AwardBurroughs Wellcome Fund · 2016–2021BWF/ 1009945.02
- KPImmune Consequences of Apoptotic Intestinal Epithelial Cell Sampling on Innate and Adaptive ImmunityCrohn's and Colitis Foundation of America · 2020–2020CCFA 602723
- PISanofi Innovation AwardSanofi S.A. · 2019–2019ContractSUS 192320-01
- PIDual Targeting of Toll-like and Nod-like Receptors in Tumor ImmunotherapyLeukemia & Lymphoma Society · 2016–2019LLS 1328-15
- PIDual Targeting of Toll-Like and Nod-Like Receptors in Cancer ImmunotherapyDaedalus Fund for Innovation (Weill Cornell) · 2018–2019DFI 183292-01
- PIRequest for femurs from FABP5 micePresident and Fellows of Harvard College · 2017–2018Contract
- Sub-PIInnate/Adaptive Immune Interactions in Gut InflammationNational Institute of Diabetes and Digestive and Kidney Diseases · 2017–2017 · via Mount Sinai School of MedicineP01DK072201-10
- PIControl of protective immunity by innate pathways sensing bacterial viabilityNIAID · 2012–2016 · via NIH RePORTERR01AI095245-04
- PIThe Regulatory Control Mechanisms of Cross-presentation by Toll-like ReceptorsNIAID · 2008–2013 · via NIH RePORTERR01AI073899-05
- PIThe Regulatory Control Mechanisms of Cross-presentation by Toll-like ReceptorsNIAID · 2007–2008 · via NIH RePORTERR56AI073899-01
Honors & distinctions
- Searle Scholars Program · Searle Scholars Program · 2007
Clinical research
Active
1 study- PIRecurrent Neoantigen LNP-RNA Vaccination for Lynch Syndrome Colorectal Cancer ImmunopreventionWeill Medical College of Cornell University · OPEN TO ACCRUAL (as of 2025)
Completed & closed trials (1)
- PIA T cell Biomarker for Protective COVID-19 ImmunityWeill Medical College of Cornell University · CLOSED TO ACCRUAL (as of 2022)
Available technologies
- Inflammasome Agonists for Vaccine and Immunotherapy8473PCT filedPoC Data
News mentions
- Scientists Uncover How the Intestine Balances Cell Growth and MaintenanceApril 22, 2026
A new preclinical study from Weill Cornell Medicine found that the protein caspase-5 (CASP5), long thought to be a foot soldier in the body’s defense against bacterial infection, does not actually help clear invaders the way its close cousin caspase-4 (CASP4) does.
- Immune Complex Shaves Stem Cells to Protect against CancerJanuary 13, 2025
A group of immune proteins called the inflammasome can help prevent blood stem cells from becoming malignant by removing certain receptors from their surfaces and blocking cancer gene activity, according to a preclinical study by Weill Cornell Medicine investigators.
- Prestigious Awards Recognize Weill Cornell Faculty and StudentsJune 1, 2021
Weill Cornell Medicine faculty members were honored with awards for their exemplary achievements in medical research, education and care at the institution’s virtual commencement ceremony on May 20.
- A "Plan B" for Defense Points Toward Better VaccinesApril 23, 2021
Cells can use a backup mechanism to alert the immune system to viral infections when their normal responses are inhibited, according to new research by scientists at Weill Cornell Medicine.
- Awards and Honors Across Weill Cornell Medicine - April 22, 2021April 22, 2021
Awards, honors, prizes and achievements for the month of April.
Show 4 more mentions
- $750K Awarded for Intercampus ResearchMarch 8, 2021
The Office of Academic Integration (OVPAI) has awarded $750,000 in seed grants to 10 studies ranging from refugee health and legal rights, to a vaccine treating fentanyl addiction and overdose, to pancreatic cancer and antibiotic tolerance.
- Mission Possible: Weill Cornell Medicine Launches an Unprecedented Research Effort in the Battle Against COVID-19March 2, 2021
Soon after the first case of COVID-19 was reported in New York City last March, a group of about 10 physician-scientists at Weill Cornell Medicine met to discuss a pressing issue: there were no known treatments for severe cases of the disease.
- Study Recruiting 1,000 Healthcare Workers to Investigate Underlying Factors Driving COVID-19 OutcomesOctober 6, 2020
A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms?
- COVID-19 Research Grants Support Weill Cornell Medicine InvestigatorsSeptember 11, 2020
Weill Cornell Medicine has awarded eight grants of $100,000 each to faculty for a variety of research projects on COVID-19, funded by the institution’s Board of Overseers and additional donors. The grants will support studies aimed at understanding fundamental aspects of the disease, the body’s immune response and social determinants of health that affect COVID-19 outcomes.
Mentoring
PhD · 1
- JRJohn RallsPharmacology (PhD) · Class of 2025
Postdoc · 10
- SWShuang WuPostdoc mentee · 2025–2026
- AAAmandine AKAPostdoc mentee · 2023–2024
- VDVinica DharPostdoc mentee · 2023–2024
- BJBaosen JiaPostdoc mentee · 2021–2023
- BSBarzan SadiqPostdoc mentee · 2020–2021